Exisulind

Revision as of 02:29, 9 August 2012 by WikiBot (talk | contribs) (Bot: Automated text replacement (-{{SIB}} + & -{{EJ}} + & -{{EH}} + & -{{Editor Join}} + & -{{Editor Help}} +))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

WikiDoc Resources for Exisulind

Articles

Most recent articles on Exisulind

Most cited articles on Exisulind

Review articles on Exisulind

Articles on Exisulind in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Exisulind

Images of Exisulind

Photos of Exisulind

Podcasts & MP3s on Exisulind

Videos on Exisulind

Evidence Based Medicine

Cochrane Collaboration on Exisulind

Bandolier on Exisulind

TRIP on Exisulind

Clinical Trials

Ongoing Trials on Exisulind at Clinical Trials.gov

Trial results on Exisulind

Clinical Trials on Exisulind at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Exisulind

NICE Guidance on Exisulind

NHS PRODIGY Guidance

FDA on Exisulind

CDC on Exisulind

Books

Books on Exisulind

News

Exisulind in the news

Be alerted to news on Exisulind

News trends on Exisulind

Commentary

Blogs on Exisulind

Definitions

Definitions of Exisulind

Patient Resources / Community

Patient resources on Exisulind

Discussion groups on Exisulind

Patient Handouts on Exisulind

Directions to Hospitals Treating Exisulind

Risk calculators and risk factors for Exisulind

Healthcare Provider Resources

Symptoms of Exisulind

Causes & Risk Factors for Exisulind

Diagnostic studies for Exisulind

Treatment of Exisulind

Continuing Medical Education (CME)

CME Programs on Exisulind

International

Exisulind en Espanol

Exisulind en Francais

Business

Exisulind in the Marketplace

Patents on Exisulind

Experimental / Informatics

List of terms related to Exisulind


Overview

Exisulind is a drug used to treat cancer. It acts by inhibiting the enzyme cyclic guanosine monophosphate phosphodiesterase. Tademark by OSI Pharmaceuticals is Aptosyn. Template:WH Template:WS